Association of CD34 + Cell Dose with Progression-free Survival after Allogeneic Peripheral Blood Hematopoietic Cell Transplantation in Children with Hematologic Malignancies.
Transplantation proceedings（2023）
摘要
This study reinforced that CD34+ cell dose at the time of allo-HSCT retained a positive impact on PFS.
更多查看译文
关键词
progression-free
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要